Free Trial

MarketBeat Instant News Alerts

Surgery Partners logo with Medical background

JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)

JPMorgan Chase & Co. reissued a "neutral" rating and issued a $27.00 price objective on shares of Surgery Partners in a report on Thursday.

NASDAQ:SGRY
Read JPMorgan Chase & Co. Begins Coverage on Surgery Partners (NASDAQ:SGRY)
InnovAge logo with Medical background

InnovAge (NASDAQ:INNV) Earns Underweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. restated an "underweight" rating and set a $5.00 price target on shares of InnovAge in a research report on Thursday.

NASDAQ:INNV
Read InnovAge (NASDAQ:INNV) Earns Underweight Rating from Analysts at JPMorgan Chase & Co.
Concentra Group Holdings Parent logo with Medical background

Concentra Group Holdings Parent (NYSE:CON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued an "overweight" rating and set a $31.00 price target on shares of Concentra Group Holdings Parent in a research report on Thursday.

NYSE:CON
Read Concentra Group Holdings Parent (NYSE:CON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.
Target logo with Retail/Wholesale background

Target (NYSE:TGT) Coverage Initiated by Analysts at Wolfe Research

Wolfe Research began coverage on Target in a research report on Thursday. They set an "underperform" rating and a $80.00 price target on the stock.

NYSE:TGT
Read Target (NYSE:TGT) Coverage Initiated by Analysts at Wolfe Research
Aveanna Healthcare logo with Medical background

Aveanna Healthcare (NASDAQ:AVAH) Upgraded by JPMorgan Chase & Co. to "Neutral" Rating

JPMorgan Chase & Co. raised Aveanna Healthcare from an "underweight" rating to a "neutral" rating and increased their price target for the stock from $6.00 to $10.00 in a research note on Thursday.

NASDAQ:AVAH
Read Aveanna Healthcare (NASDAQ:AVAH) Upgraded by JPMorgan Chase & Co. to "Neutral" Rating
Dollar Tree logo with Retail/Wholesale background

Dollar Tree (NASDAQ:DLTR) Now Covered by Analysts at Wolfe Research

Wolfe Research began coverage on Dollar Tree in a report on Thursday. They issued a "peer perform" rating on the stock.

NASDAQ:DLTR
Read Dollar Tree (NASDAQ:DLTR) Now Covered by Analysts at Wolfe Research

Trending News

All MarketBeat Instant News Alerts

CRISPR Therapeutics logo with Medical background

CRISPR Therapeutics (NASDAQ:CRSP) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

NASDAQ:CRSP
Read CRISPR Therapeutics (NASDAQ:CRSP) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.
NIKE logo with Consumer Discretionary background

NIKE (NYSE:NKE) Raised to Outperform at Royal Bank Of Canada

NYSE:NKE
Read NIKE (NYSE:NKE) Raised to Outperform at Royal Bank Of Canada
Praxis Precision Medicines logo with Medical background

Jones Trading Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)

NASDAQ:PRAX
Read Jones Trading Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX)
Ceragon Networks logo with Computer and Technology background

Ceragon Networks' (CRNT) Buy Rating Reiterated at Needham & Company LLC

NASDAQ:CRNT
Read Ceragon Networks' (CRNT) Buy Rating Reiterated at Needham & Company LLC
Vale logo with Basic Materials background

Vale (NYSE:VALE) Rating Increased to Sector Outperform at Scotiabank

NYSE:VALE
Read Vale (NYSE:VALE) Rating Increased to Sector Outperform at Scotiabank
CSX logo with Transportation background

Royal Bank Of Canada Upgrades CSX (NASDAQ:CSX) to Outperform

NASDAQ:CSX
Read Royal Bank Of Canada Upgrades CSX (NASDAQ:CSX) to Outperform
WhiteFiber logo with Financial Services background

WhiteFiber's (WYFI) "Buy" Rating Reiterated at Needham & Company LLC

NASDAQ:WYFI
Read WhiteFiber's (WYFI) "Buy" Rating Reiterated at Needham & Company LLC
Maze Therapeutics logo with Medical background

Maze Therapeutics' (MAZE) Buy Rating Reaffirmed at HC Wainwright

NASDAQ:MAZE
Read Maze Therapeutics' (MAZE) Buy Rating Reaffirmed at HC Wainwright
Roivant Sciences logo with Medical background

HC Wainwright Issues Positive Forecast for Roivant Sciences (NASDAQ:ROIV) Stock Price

NASDAQ:ROIV
Read HC Wainwright Issues Positive Forecast for Roivant Sciences (NASDAQ:ROIV) Stock Price
Innate Pharma logo with Medical background

Innate Pharma (NASDAQ:IPHA) Lowered to Neutral Rating by HC Wainwright

NASDAQ:IPHA
Read Innate Pharma (NASDAQ:IPHA) Lowered to Neutral Rating by HC Wainwright
monday.com logo with Computer and Technology background

monday.com's (MNDY) "Buy" Rating Reiterated at Needham & Company LLC

NASDAQ:MNDY
Read monday.com's (MNDY) "Buy" Rating Reiterated at Needham & Company LLC
MannKind logo with Medical background

MannKind (NASDAQ:MNKD) Receives "Buy" Rating from HC Wainwright

NASDAQ:MNKD
Read MannKind (NASDAQ:MNKD) Receives "Buy" Rating from HC Wainwright
American Eagle Outfitters logo with Retail/Wholesale background

American Eagle Outfitters (NYSE:AEO) Now Covered by BTIG Research

NYSE:AEO
Read American Eagle Outfitters (NYSE:AEO) Now Covered by BTIG Research
Abercrombie & Fitch logo with Retail/Wholesale background

Abercrombie & Fitch (NYSE:ANF) Now Covered by Analysts at BTIG Research

NYSE:ANF
Read Abercrombie & Fitch (NYSE:ANF) Now Covered by Analysts at BTIG Research
Vertical Aerospace logo with Aerospace background

Vertical Aerospace's (EVTL) "Buy" Rating Reaffirmed at HC Wainwright

NYSE:EVTL
Read Vertical Aerospace's (EVTL) "Buy" Rating Reaffirmed at HC Wainwright
Arqit Quantum logo with Computer and Technology background

Arqit Quantum (NASDAQ:ARQQ) Given Buy Rating at HC Wainwright

NASDAQ:ARQQ
Read Arqit Quantum (NASDAQ:ARQQ) Given Buy Rating at HC Wainwright
Vertical Aerospace logo with Aerospace background

Needham & Company LLC Reiterates Buy Rating for Vertical Aerospace (NYSE:EVTL)

NYSE:EVTL
Read Needham & Company LLC Reiterates Buy Rating for Vertical Aerospace (NYSE:EVTL)
Amicus Therapeutics logo with Medical background

Amicus Therapeutics (NASDAQ:FOLD) Rating Increased to Buy at Needham & Company LLC

NASDAQ:FOLD
Read Amicus Therapeutics (NASDAQ:FOLD) Rating Increased to Buy at Needham & Company LLC
Zoom Communications logo with Computer and Technology background

Needham & Company LLC Reiterates "Buy" Rating for Zoom Communications (NASDAQ:ZM)

NASDAQ:ZM
Read Needham & Company LLC Reiterates "Buy" Rating for Zoom Communications (NASDAQ:ZM)
Kirby logo with Transportation background

Kirby's (KEX) Buy Rating Reiterated at BTIG Research

NYSE:KEX
Read Kirby's (KEX) Buy Rating Reiterated at BTIG Research
CryoPort logo with Transportation background

CryoPort (NASDAQ:CYRX) Given New $15.00 Price Target at BTIG Research

NASDAQ:CYRX
Read CryoPort (NASDAQ:CYRX) Given New $15.00 Price Target at BTIG Research
monday.com logo with Computer and Technology background

Piper Sandler Cuts monday.com (NASDAQ:MNDY) Price Target to $275.00

NASDAQ:MNDY
Read Piper Sandler Cuts monday.com (NASDAQ:MNDY) Price Target to $275.00
Rezolute logo with Medical background

BTIG Research Reiterates "Buy" Rating for Rezolute (NASDAQ:RZLT)

NASDAQ:RZLT
Read BTIG Research Reiterates "Buy" Rating for Rezolute (NASDAQ:RZLT)
Oruka Therapeutics logo with Medical background

Oruka Therapeutics (NASDAQ:ORKA) Stock Price Expected to Rise, BTIG Research Analyst Says

NASDAQ:ORKA
Read Oruka Therapeutics (NASDAQ:ORKA) Stock Price Expected to Rise, BTIG Research Analyst Says